Physician profile
Patrick H Mcdermott
NPI 1629188131
$1,739.76
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,740.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $299.43 | 2019 | |
| Janssen Pharmaceuticals, INC | $160.02 | 2019 | |
| Amgen INC. | $153.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $123.88 | 2019 | |
| Lilly USA, LLC | $111.88 | 2019 | |
| Abbott Laboratories | $108.28 | 2019 | |
| Abbvie INC. | $90.85 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $90.85 | 2019 | |
| Merck Sharp & Dohme LLC | $77.81 | 2019 | |
| Eisai INC. | $58.02 | 2019 | |
| Amarin Pharma, INC. | $53.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.14 | 2019 | |
| Becton, Dickinson and Company | $48.63 | 2019 | |
| Dexcom, INC. | $44.80 | 2019 | |
| Ibsa Pharma INC. | $43.78 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $39.41 | 2019 | |
| Radius Health, INC. | $39.36 | 2019 | |
| Ascensia Diabetes Care US INC. | $34.04 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.36 | 2019 | |
| Lifescan, INC. | $18.56 | 2019 | |
| Valeritas, INC. | $17.47 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.38 | 2019 | |
| Gilead Sciences, INC. | $16.23 | 2019 | |
| Allergan, INC. | $13.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcdermott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.